e.g. Tata motors, Reliance MF, 500570

Piramal Pharma Ltd. - Research Center

543635 PPLPHARMA Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 4,390.11 3,443.22 3,094.95 2,938.81
Expenses
Material consumed 2,194.78 1,851.29 1,537.18 1,275.27
Manufacturing expenses 112.89 107.94 68.97 68.08
Personnel expenses 613.93 548.50 425.30 395.15
Selling expenses 107.33 138.71 122.94 85.53
Adminstrative expenses 743.26 699.25 543.26 495.85
Expenses capitalised - - - -
Cost of sales 3,772.19 3,345.69 2,697.65 2,319.88
Operating profit 617.92 97.53 397.30 618.93
Other recurring income 202.06 341.07 223.59 197.97
Adjusted PBDIT 819.98 438.60 620.89 816.90
Financial expenses 107.10 115.87 53.55 4.71
Depreciation 205.26 192.08 130.64 143.64
Other write offs - - - -
Adjusted PBT 507.62 130.65 436.70 668.55
Tax charges 116.40 54.19 81.18 115.28
Adjusted PAT 391.22 76.46 355.52 553.27
Non recurring items -3.78 -9.53 -12.18 15.77
Other non cash adjustments - - - -
Reported net profit 387.44 66.93 343.34 569.04
Earnigs before appropriation 1,359.23 985.19 912.38 569.04
Equity dividend - - - -
Preference dividend - - - -
Dividend tax - - - -
Retained earnings 1,359.23 985.19 912.38 569.04
Close
Add Piramal Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Piramal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback